Uwe Reusch

Person

Maikammer, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific EGFR/CD16 antigen-binding protein
- Patent number 12,076,384
- Issue date Sep 3, 2024
- Affimed GMBH
- Michael Kluge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent FV antibodies
- Patent number 11,572,415
- Issue date Feb 7, 2023
- Affimed GMBH
- Kristina Ellwanger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination of an anti-CD16A antibody with a cytokine
- Patent number 11,535,672
- Issue date Dec 27, 2022
- Affimed GMBH
- Joachim Koch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific EGFR/CD16 antigen-binding protein
- Patent number 11,510,972
- Issue date Nov 29, 2022
- Affimed GMBH
- Michael Kluge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tandem diabody for CD16A-directed NK-cell engagement
- Patent number 11,180,558
- Issue date Nov 23, 2021
- Affimed GMBH
- Thorsten Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy
- Patent number 11,167,029
- Issue date Nov 9, 2021
- Affimed GMBH
- Martin Treder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NK cell engaging antibody fusion constructs
- Patent number 11,001,633
- Issue date May 11, 2021
- Affimed GMBH
- Michael Tesar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 10,626,190
- Issue date Apr 21, 2020
- Amphivena Therapeutics, Inc.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody binding sites specific for EGFRvIII
- Patent number 10,273,309
- Issue date Apr 30, 2019
- AFFEMED GMBH
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD3 binding domains
- Patent number 10,066,015
- Issue date Sep 4, 2018
- Affirmed GmbH
- Eugene Zhukovsky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 9,803,029
- Issue date Oct 31, 2017
- AMPHIVENA THERAPEUTICS, INC.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD16 binding molecules
- Patent number 9,701,750
- Issue date Jul 11, 2017
- Affimed GMBH
- Karin Hoffmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for use in the treatment of Alzheimer's disease
- Patent number 9,365,647
- Issue date Jun 14, 2016
- UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG
- Stefan Franz Thomas Weiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human CD3-specific antibody with immunosuppressive properties
- Patent number 9,226,962
- Issue date Jan 5, 2016
- Affimed GMBH
- Fabrice Le Gall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 9,212,225
- Issue date Dec 15, 2015
- AMPHIVENA THERAPEUTICS, INC.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD16 binding molecules
- Patent number 9,035,026
- Issue date May 19, 2015
- Affimed GMBH
- Karin Hoffmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of an antibody against the laminin receptor or laminin receptor...
- Patent number 7,901,677
- Issue date Mar 8, 2011
- Affimed Therapeutics AG
- Melvyn Little
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor...
- Patent number 7,507,797
- Issue date Mar 24, 2009
- Affimed Therapeutics AG
- Stefan Knackmuss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
DUPLEXBODIES
- Publication number 20240376208
- Publication date Nov 14, 2024
- Affimed GmbH
- Uwe REUSCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS FOR TREATMENTS
- Publication number 20240294647
- Publication date Sep 5, 2024
- Affimed GmbH
- Michael Tesar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRISPECIFIC BINDERS
- Publication number 20230365709
- Publication date Nov 16, 2023
- Affimed GmbH
- Thorsten ROSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC EGFR/CD16 ANTIGEN-BINDING PROTEIN
- Publication number 20230190900
- Publication date Jun 22, 2023
- Affimed GmbH
- Michael Kluge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE
- Publication number 20220048994
- Publication date Feb 17, 2022
- Melvyn Little
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tandem Diabody for CD16A-directed NK-cell Engagement
- Publication number 20220041717
- Publication date Feb 10, 2022
- Affimed GmbH
- Thorsten ROSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS FOR TREATMENTS
- Publication number 20210253698
- Publication date Aug 19, 2021
- Affimed GmbH
- Michael Tesar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cryopreserved NK cells preloaded with an antibody construct
- Publication number 20210169936
- Publication date Jun 10, 2021
- Affimed GmbH
- Uwe REUSCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20210024654
- Publication date Jan 28, 2021
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC EGFR/CD16 ANTIGEN-BINDING PROTEIN
- Publication number 20200405833
- Publication date Dec 31, 2020
- Affimed GmbH
- Michael Kluge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS
- Publication number 20200109202
- Publication date Apr 9, 2020
- Affimed GmbH
- Michael Tesar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF AN ANTI-CD16A ANTIBODY WITH A CYTOKINE
- Publication number 20200010547
- Publication date Jan 9, 2020
- Joachim Koch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tandem Diabody for CD16A-directed NK-cell Engagement
- Publication number 20190345249
- Publication date Nov 14, 2019
- Thorsten Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTIVALENT FV ANTIBODIES
- Publication number 20190040155
- Publication date Feb 7, 2019
- Affimed GmbH
- Kristina ELLWANGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20180291113
- Publication date Oct 11, 2018
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF A CD30XCD16 ANTIBODY WITH A PD-1 ANTAGONIST FOR THERAPY
- Publication number 20180085456
- Publication date Mar 29, 2018
- Affimed GmbH
- Martin TREDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE
- Publication number 20170037128
- Publication date Feb 9, 2017
- Affimed GmbH
- Melvyn LITTLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
- Publication number 20160361413
- Publication date Dec 15, 2016
- UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG
- Stefan Franz Thomas Weiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20160194409
- Publication date Jul 7, 2016
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII
- Publication number 20160152728
- Publication date Jun 2, 2016
- Affimed GmbH
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD3 BINDING DOMAINS
- Publication number 20160039934
- Publication date Feb 11, 2016
- Affimed GmbH
- Eugene ZHUKOVSKY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20160002333
- Publication date Jan 7, 2016
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD16 BINDING MOLECULES
- Publication number 20150218275
- Publication date Aug 6, 2015
- Affimed GmbH
- Karin Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
- Publication number 20140220041
- Publication date Aug 7, 2014
- UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG
- Stefan Franz Thomas Weiss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMAN CD3-SPECIFIC ANTIBODY WITH IMMUNOSUPPRESSIVE PROPERTIES
- Publication number 20130115213
- Publication date May 9, 2013
- AFFIMED THERAPEUTICS, AG
- Fabrice LE GALL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-cd16 binding molecules
- Publication number 20090214574
- Publication date Aug 27, 2009
- AFFIMED THERAPEUTICS AG
- Karin Hoffmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Single-chain antibody acting against 37 kda/67 kda laminin receptor...
- Publication number 20070041977
- Publication date Feb 22, 2007
- Stefan Knackmuss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human cd3-specific antibody with immunosuppressive properties
- Publication number 20060233787
- Publication date Oct 19, 2006
- Fabrice Le Gall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dimeric and multimeric antigen binding structure
- Publication number 20050079170
- Publication date Apr 14, 2005
- Fabrice Le Gall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Bispecific EGFR/CD16 antigen-binding protein

Multivalent FV antibodies

Combination of an anti-CD16A antibody with a cytokine

Bispecific EGFR/CD16 antigen-binding protein

Tandem diabody for CD16A-directed NK-cell engagement

Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy

NK cell engaging antibody fusion constructs

Bispecific CD33 and CD3 binding proteins

Antibody binding sites specific for EGFRvIII

CD3 binding domains

Bispecific CD33 and CD3 binding proteins

Anti-CD16 binding molecules

Compounds for use in the treatment of Alzheimer's disease

Human CD3-specific antibody with immunosuppressive properties

Bispecific CD33 and CD3 binding proteins

Anti-CD16 binding molecules

Use of an antibody against the laminin receptor or laminin receptor...

Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor...

Patents Applicationslast 30 patents

DUPLEXBODIES

USES OF NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS FOR TREATMENTS

TRISPECIFIC BINDERS

BISPECIFIC EGFR/CD16 ANTIGEN-BINDING PROTEIN

TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE

Tandem Diabody for CD16A-directed NK-cell Engagement

USES OF NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS FOR TREATMENTS

Cryopreserved NK cells preloaded with an antibody construct

Bispecific CD33 and CD3 Binding Proteins

BISPECIFIC EGFR/CD16 ANTIGEN-BINDING PROTEIN

NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS

COMBINATION OF AN ANTI-CD16A ANTIBODY WITH A CYTOKINE

Tandem Diabody for CD16A-directed NK-cell Engagement

MULTIVALENT FV ANTIBODIES

Bispecific CD33 and CD3 Binding Proteins

COMBINATION OF A CD30XCD16 ANTIBODY WITH A PD-1 ANTAGONIST FOR THERAPY

TRIFUNCTIONAL ANTIGEN-BINDING MOLECULE

COMPOUNDS FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE

Bispecific CD33 and CD3 Binding Proteins

ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII

CD3 BINDING DOMAINS

Bispecific CD33 and CD3 Binding Proteins

ANTI-CD16 BINDING MOLECULES

COMPOUNDS FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE

HUMAN CD3-SPECIFIC ANTIBODY WITH IMMUNOSUPPRESSIVE PROPERTIES

Anti-cd16 binding molecules

Single-chain antibody acting against 37 kda/67 kda laminin receptor...

Human cd3-specific antibody with immunosuppressive properties

Dimeric and multimeric antigen binding structure